Macasling, Jm E.
HRN: 14-27-95 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2022
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
08/31/2022
09/07/2022
PO
5ml
BID
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes